Summary
- Current Price
- As of today, PHAT price is $7.08, down -3.01% on
- Current Price All-Time High
- PHAT price is currently -89.03% below its historical high of $64.54 set on
- Market Cap
- PHAT current market cap is $573M, down -34.40% year-over-year
- Revenue
- PHAT current annual revenue is $175.11M, up +216.93% year-over-year
- Next Earnings
- The next earnings release for PHAT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Phathom Pharmaceuticals, Inc. |
| Ticker | NASDAQ: PHAT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | phathompharma.com |
| Employees | 427 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $7.08 | |
| Price, 1D Change | -3.01% | |
| $573M | ||
| - | ||
| - | ||
| 0.60 | ||
| $175.11M | ||
| Revenue, 1Y Change | +216.93% | |
| -$3.03 | ||
| EPS, 1Y Change | +42.66% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.03 | ||
| EPS Estimate | -$0.03 | N/A |
| EPS Est. Change | +99.02% | N/A |
| $175.11M | ||
| Revenue Estimate | $316.07M | N/A |
| Revenue Est. Change | +80.50% | N/A |
| Current Price | $7.08 | |
| Price Target | $21.00 | - |
| Price Tgt. Change | +196.61% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.70 | -$5.29 | -12.54% | |
| -$2.33 | -$3.03 | -30.10% | |
| -$0.03 | N/A | +99.02% | |
| $1.08 | N/A | +135.46% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $51.25M | $55.25M | +7.82% | |
| $174.73M | $175.11M | +0.22% | |
| $316.07M | N/A | +80.50% | |
| $495.10M | N/A | +182.74% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $7.08 | |
| $11.44 | ||
| $8.81 | ||
| - | ||
| - | ||
| - | ||
| 0.60 | ||
| $0.44 | ||
| 34.20 | ||
| 63.57% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $175.11M | ||
| -$3.03 | ||
| $0.00 | ||
| 87.09% | ||
| -$159.99M | ||
| -91.36% | ||
| -$221.25M | ||
| -126.35% | ||
| -$159.35M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -1.34 | ||
| 1.73 | ||
| 1.69 | ||
| - | ||
| 3 | ||
| -6.38 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 2.39 | ||
| -1.66 | ||
| -23.48 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$438.17M | ||
| $129.97M | ||
| $259.80M | ||
| $228.97M | ||
| $697.97M | ||
| $132.04M | ||
| $589.17M | ||
| $27.90M | ||
| $4.98M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $396.36M | ||
| $312.50M | ||
| $22.60M | ||
| $279.72M | ||
| $633.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$166.78M | ||
| -$229.00K | ||
| -$288.00K | ||
| $229.00K | ||
| -$167.00M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Leerink Partners | ||
| Barclays | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Barclays | → | |
| Guggenheim | → | |
| Barclays | ||
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with PHAT
FAQ
- What is the ticker symbol for Phathom Pharmaceuticals, Inc.?
- The ticker symbol for Phathom Pharmaceuticals, Inc. is NASDAQ:PHAT
- Does Phathom Pharmaceuticals, Inc. pay dividends?
- No, Phathom Pharmaceuticals, Inc. does not pay dividends
- What sector is Phathom Pharmaceuticals, Inc. in?
- Phathom Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Phathom Pharmaceuticals, Inc. in?
- Phathom Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Phathom Pharmaceuticals, Inc. based in?
- Phathom Pharmaceuticals, Inc. is headquartered in United States
- When did Phathom Pharmaceuticals, Inc. go public?
- Phathom Pharmaceuticals, Inc. initial public offering (IPO) was on October 25, 2019
- Is Phathom Pharmaceuticals, Inc. in the S&P 500?
- No, Phathom Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Phathom Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Phathom Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Phathom Pharmaceuticals, Inc. in the Dow Jones?
- No, Phathom Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Phathom Pharmaceuticals, Inc. last earnings report?
- Phathom Pharmaceuticals, Inc.'s most recent earnings report was on July 30, 2026
- When does Phathom Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Phathom Pharmaceuticals, Inc. is October 29, 2026
Data Sources & References
- PHAT Official Website www.phathompharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1783183/000119312526073379/0001193125-26-073379-index.htm
- PHAT Profile on Yahoo Finance finance.yahoo.com/quote/PHAT
- PHAT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/phat
